Gensia Lands Contract With Drug Purchaser
- Share via
IRVINE — Gensia Laboratories has been awarded a contract by Premier Inc. to provide injectable drugs over a two-year period.
The agreement with Premier, which makes purchases of more than $10 billion annually for 1,700 hospitals and health systems nationwide, could generate $10 million in new product sales, according to Gensia Laboratories’ parent company, Gensia Inc. in San Diego.
Terms of the agreement were not disclosed.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
